Michel Colle

533 total citations
9 papers, 370 citations indexed

About

Michel Colle is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, Michel Colle has authored 9 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Michel Colle's work include Hypothalamic control of reproductive hormones (3 papers), Growth Hormone and Insulin-like Growth Factors (3 papers) and Sexual Differentiation and Disorders (3 papers). Michel Colle is often cited by papers focused on Hypothalamic control of reproductive hormones (3 papers), Growth Hormone and Insulin-like Growth Factors (3 papers) and Sexual Differentiation and Disorders (3 papers). Michel Colle collaborates with scholars based in France, United States and Japan. Michel Colle's co-authors include Najiba Lahlou, Jean‐Claude Carel, Marc Roger, Yves Morel, Cécile Teinturier, M Bost, P Garandeau, Andrew V. Schally, P. Berlier and Sylvain Larroque and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Archives of Disease in Childhood and European Journal of Endocrinology.

In The Last Decade

Michel Colle

9 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michel Colle France 8 210 157 141 127 46 9 370
Elisa Vaiani Argentina 9 49 0.2× 125 0.8× 115 0.8× 151 1.2× 44 1.0× 22 328
PM Holterhus Germany 9 32 0.2× 204 1.3× 128 0.9× 149 1.2× 21 0.5× 13 335
C Terzi Italy 5 197 0.9× 154 1.0× 84 0.6× 40 0.3× 65 1.4× 10 350
Leona Fishman Canada 5 63 0.3× 53 0.3× 233 1.7× 134 1.1× 22 0.5× 9 366
S.M.P.F. de Muinck Keizer-Schrama Netherlands 7 92 0.4× 125 0.8× 85 0.6× 56 0.4× 59 1.3× 9 321
Hílton Kuperman Brazil 10 25 0.1× 259 1.6× 150 1.1× 158 1.2× 47 1.0× 29 380
Charalambos Hadjiathanasiou Greece 10 129 0.6× 140 0.9× 261 1.9× 217 1.7× 81 1.8× 16 488
GS Conway United Kingdom 4 58 0.3× 157 1.0× 322 2.3× 162 1.3× 27 0.6× 5 371
Eduardo Chaler Argentina 13 86 0.4× 316 2.0× 244 1.7× 198 1.6× 113 2.5× 29 583
A Rossodivita Italy 10 131 0.6× 54 0.3× 83 0.6× 62 0.5× 57 1.2× 33 323

Countries citing papers authored by Michel Colle

Since Specialization
Citations

This map shows the geographic impact of Michel Colle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Colle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Colle more than expected).

Fields of papers citing papers by Michel Colle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Colle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Colle. The network helps show where Michel Colle may publish in the future.

Co-authorship network of co-authors of Michel Colle

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Colle. A scholar is included among the top collaborators of Michel Colle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Colle. Michel Colle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Rothenbühler, Anya, Laure Esterle, Iva Gueorguieva, et al.. (2017). Two-year recombinant human growth hormone (rhGH) treatment is more effective in pre-pubertal compared to pubertal short children with X-linked hypophosphatemic rickets (XLHR). Growth Hormone & IGF Research. 36. 11–15. 25 indexed citations
2.
Rapaport, Robert, Olaf Schmidt, Michel Colle, et al.. (2013). Validation and ease of use of a new pen device for self-administration of recombinant human growth hormone: results from a two-center usability study. Medical Devices Evidence and Research. 6. 141–141. 10 indexed citations
3.
Martinerie, Laëtitia, Yves Morel, Claire-Lise Gay, et al.. (2012). Impaired puberty, fertility, and final stature in 45,X/46,XY mixed gonadal dysgenetic patients raised as boys. European Journal of Endocrinology. 166(4). 687–694. 56 indexed citations
5.
Raynaud, Jean‐Pierre, et al.. (2010). Comparison of oral versus transdermal testosterone supplementation in hypogonadal men. Hormone Molecular Biology and Clinical Investigation. 2(3). 301–309. 1 indexed citations
6.
Carel, Jean‐Claude, et al.. (2002). Treatment of Central Precocious Puberty by Subcutaneous Injections of Leuprorelin 3-Month Depot (11.25 mg). The Journal of Clinical Endocrinology & Metabolism. 87(9). 4111–4116. 81 indexed citations
7.
Carel, Jean‐Claude, Najiba Lahlou, Laura Guazzarotti, et al.. (1995). Treatment of central precocious puberty with depot leuprorelin. European Journal of Endocrinology. 132(6). 699–704. 52 indexed citations
8.
Roger, Marc, Jean‐Louis Chaussain, P. Berlier, et al.. (1986). Long Term Treatment of Male and Female Precocious Puberty by Periodic Administration of a Long-Acting Preparation of D-Trp6-Luteinizing Hormone-Releasing Hormone Microcapsules. The Journal of Clinical Endocrinology & Metabolism. 62(4). 670–677. 87 indexed citations
9.
Colle, Michel, et al.. (1977). The tall girl. Prediction of mature height and management.. Archives of Disease in Childhood. 52(2). 118–120. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026